We are live on ! Find out more
Balyasny Asset Management

Balyasny Asset Management Portfolio holdings

AUM $80.2B
1-Year Est. Return 51.53%
This Fund
S&P 500
This Quarter Est. Return
+12.46%
1 Year Est. Return
+51.53%
3 Year Est. Return
+149.76%
5 Year Est. Return
+199.38%
10 Year Est. Return
+1,172.21%
AUM
$36.5B
AUM Growth
+$3.93B
Cap. Flow
+$651M
Cap. Flow %
1.78%
Top 10 Hldgs %
7.68%
Holding
3,587
New
780
Increased
747
Reduced
671
Closed
866

Top Buys

Rank Stock Value
1
V icon
Visa
V
+$223M
2
TJX icon
TJX Companies
TJX
+$191M
3
TDG icon
TransDigm Group
TDG
+$157M
4
IR icon
Ingersoll Rand
IR
+$155M
5
BP icon
BP
BP
+$152M

Sector Composition

Rank Sector Weight
1 Industrials 11.39%
2 Financials 11.28%
3 Technology 9.98%
4 Consumer Discretionary 9.35%
5 Healthcare 8.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ORGNW
2076
DELISTED
Origin Materials Inc Warrants
ORGNW
$218K ﹤0.01%
249,999
HROW icon
2077
Harrow
HROW
$1.5B
$217K ﹤0.01%
+14,719
New +$176K
SPR
2078
DELISTED
Spirit AeroSystems
SPR
$217K ﹤0.01%
7,328
-645,339
-99% -$16.8M
ALDX icon
2079
Aldeyra Therapeutics
ALDX
$94.1M
$217K ﹤0.01%
+31,120
New +$178K
WIX icon
2080
WIX.com
WIX
$3.1B
$216K ﹤0.01%
2,805
-719
-20% -$58.1K
SEER icon
2081
Seer Inc
SEER
$115M
$213K ﹤0.01%
36,786
+26,247
+249% +$177K
AVIR icon
2082
Atea Pharmaceuticals
AVIR
$410M
$213K ﹤0.01%
44,346
-706,727
-94% -$3.58M
KOF icon
2083
Coca-Cola Femsa
KOF
$22.9B
$213K ﹤0.01%
3,135
-1,368
-30% -$89.1K
DAWN
2084
DELISTED
Day One Biopharmaceuticals
DAWN
$213K ﹤0.01%
+9,883
New +$203K
PDS
2085
Precision Drilling
PDS
$1.09B
$212K ﹤0.01%
+2,765
New +$199K
XPOF icon
2086
Xponential Fitness
XPOF
$206M
$212K ﹤0.01%
+9,247
New +$191K
MGNI icon
2087
Magnite
MGNI
$3.55B
$212K ﹤0.01%
+20,010
New +$183K
NXE icon
2088
NexGen Energy
NXE
$6.97B
$211K ﹤0.01%
47,693
+15,064
+46% +$62.8K
WTTR icon
2089
Select Water Solutions
WTTR
$2.69B
$211K ﹤0.01%
22,831
+11,635
+104% +$98K
EVLVW
2090
DELISTED
Evolv Technologies Warrant
EVLVW
$210K ﹤0.01%
450,000
-50,000
-10% -$25K
PLAY icon
2091
Dave & Buster's
PLAY
$354M
$209K ﹤0.01%
5,906
-1,325,641
-100% -$47.9M
BELFB
2092
Bel Fuse Inc Class B
BELFB
$4.19B
$209K ﹤0.01%
+6,337
New +$207K
ORMP icon
2093
Oramed Pharmaceuticals
ORMP
$186M
$209K ﹤0.01%
+17,341
New +$135K
WING icon
2094
Wingstop
WING
$3.44B
$208K ﹤0.01%
+1,513
New +$223K
CECO icon
2095
Ceco Environmental
CECO
$4.66B
$207K ﹤0.01%
+17,739
New +$201K
BBSI icon
2096
Barrett Business Services
BBSI
$781M
$206K ﹤0.01%
+8,844
New +$200K
ADUS icon
2097
Addus HomeCare
ADUS
$2.17B
$205K ﹤0.01%
+2,061
New +$216K
ACET icon
2098
Adicet Bio
ACET
$78.4M
$204K ﹤0.01%
+1,426
New +$356K
GSBD icon
2099
Goldman Sachs BDC
GSBD
$1.11B
$204K ﹤0.01%
14,839
+2,155
+17% +$32.4K
TOWN icon
2100
Towne Bank
TOWN
$3.5B
$203K ﹤0.01%
+6,584
New +$204K

Similar funds

Balyasny Asset Management's Q4 2022 Portfolio in Review

As of Q4 2022, Balyasny Asset Management held 3,587 positions worth $36.5B, up 12% from $32.6B the previous quarter. Its ten largest holdings account for 7.7% of the portfolio.

Balyasny Asset Management's Q4 2022 filing shows 780 new, 747 increased, 671 reduced and 866 closed positions. Its largest new stake was TJX Companies: 2,589,145 shares worth $206M. The largest sale was ZENDESK INC, an estimated $300M.

By sector, the portfolio is most concentrated in Industrials at 11% of assets, down from 12% a quarter earlier, followed by Financials and Technology.

  • Balyasny Asset Management's largest Q4 2022 buy was TJX Companies: 2,589,145 shares worth $206M.
  • Balyasny Asset Management added most to Visa in Q4 2022, an estimated $223M increase.
  • Balyasny Asset Management's biggest Q4 2022 reduction was Union Pacific, cutting an estimated $252M.
  • Balyasny Asset Management fully exited ZENDESK INC in Q4 2022, selling an estimated $300M.
  • Balyasny Asset Management's ten largest holdings make up 7.7% of its $36.5B portfolio in Q4 2022.
  • Balyasny Asset Management opened 780 new positions and closed 866 in Q4 2022.
  • Balyasny Asset Management's portfolio value rose 12% quarter-over-quarter to $36.5B.

Based on Balyasny Asset Management's 13F filing for Q4 2022, filed 14 Feb 2023.